MedinCell announces the extension of the subscription period for the shares offered as part of its initial public offering September 25, 2018 September 25, 2018
MedinCell launches its initial public offering on the regulated market of Euronext in Paris September 17, 2018 September 17, 2018
MedinCell announces filing of its document de base with the AMF, the first step towards its planned IPO on the regulated market of Euronext in Paris September 5, 2018 September 5, 2018
MedinCell receives grant to develop long-acting injectable contraceptive December 7, 2017 December 7, 2017
